Table of Contents Author Guidelines Submit a Manuscript
Evidence-Based Complementary and Alternative Medicine
Volume 2018, Article ID 1491732, 6 pages
https://doi.org/10.1155/2018/1491732
Research Article

The Antibacterial Activity of Mass Galla Chinesis et Camelliae Fermentata on Helicobacter pylori Infection

1Department of Integrated Traditional Chinese and Western Medicine, Peking University First Hospital, Beijing 100034, China
2Department of Gastroenterology, Peking University First Hospital, Beijing 100034, China

Correspondence should be addressed to Xue-zhi Zhang; ten.362@ihzeux.gnahz

Received 24 September 2017; Revised 11 January 2018; Accepted 17 January 2018; Published 12 February 2018

Academic Editor: Youn C. Kim

Copyright © 2018 Jing Yu et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. B. J. Marshall and J. R. Warren, “Unidentified curved bacilli in the stomach of patients with gastritis and peptic ulceration,” The Lancet, vol. 1, no. 8390, pp. 1311–1314, 1984. View at Google Scholar · View at Scopus
  2. P. Malfertheiner, F. Megraud, C. A. O'Morain et al., “Management of Helicobacter pylori infection—the Maastricht IV/ Florence consensus report,” Gut, vol. 61, no. 5, pp. 646–664, 2012. View at Publisher · View at Google Scholar · View at Scopus
  3. B. Wang, Z.-F. Lv, Y.-H. Wang et al., “Standard triple therapy for Helicobacter pylori infection in China: a meta-analysis,” World Journal of Gastroenterology, vol. 20, no. 40, pp. 14973–14985, 2014. View at Publisher · View at Google Scholar · View at Scopus
  4. W. Z. Liu, Y. Xie, H. Cheng et al., “Fourth Chinese National Consensus report on the management of Helicobacter pylori infection,” Journal of Digestive Diseases, vol. 14, no. 5, pp. 211–221, 2013. View at Publisher · View at Google Scholar · View at Scopus
  5. S. K. Chuah, F. W. Tsay, P. I. Hsu, and D. C. Wu, “A new look at anti-Helicobacter pylori therapy,” World Journal of Gastroenterology, vol. 17, no. 35, pp. 3971–3975, 2011. View at Publisher · View at Google Scholar · View at Scopus
  6. L.-X. Zhang, W.-Y. Gao, and H.-Y. Wang, “Review of traditional Chinese medicine processed by fermentation,” Zhongguo Zhongyao Zazhi, vol. 37, no. 24, pp. 3695–3700, 2012. View at Publisher · View at Google Scholar · View at Scopus
  7. E. A. Bae, M. J. Han, N. J. Kim, and D. H. Kim, “Anti-Helicobacter pylori activity of herbal medicines,” Biological Pharmaceutical Bulletin, vol. 21, no. 9, pp. 990–992, 1998. View at Google Scholar
  8. H. A. Lee, S. Hong, Y. H. Chung, and O. Kim, “Antibacterial activities of Galla rhois extracts against Helicobacter pylori infection,” Iranian Journal of Veterinary Research, vol. 15, no. 2, pp. 99–103, 2014. View at Google Scholar · View at Scopus
  9. R. Díaz-Gómez, R. López-Solís, E. Obreque-Slier, and H. Toledo-Araya, “Comparative antibacterial effect of gallic acid and catechin against Helicobacter pylori,” LWT - Food Science and Technology, vol. 54, no. 2, pp. 331–335, 2013. View at Publisher · View at Google Scholar · View at Scopus
  10. K.-T. Chung, T. Y. Wong, C.-I. Wei, Y.-W. Huang, and Y. Lin, “Tannins and human health: a review,” Critical Reviews in Food Science and Nutrition, vol. 38, no. 6, pp. 421–464, 1998. View at Publisher · View at Google Scholar · View at Scopus
  11. M. F. Dixon, R. M. Genta, J. H. Yardley et al., “Classification and grading of gastritis. The updated Sydney System. International Workshop on the Histopathology of Gastritis,” The American Journal of Surgical Pathology, vol. 20, no. 10, pp. 1161–1181, 1996. View at Publisher · View at Google Scholar · View at Scopus
  12. L. Peng, Q. F. Gong, L. I. Xiao-Ning et al., “Determination on Contents of Gallic Acid and Ellagic Acid in Three Kinds of Processed Pieces of Galla Chinensis by RP-HPLC,” Chinese Journal of Experimental Traditional Medical Formulae, vol. 21, no. 18, pp. 76–79, 2015. View at Google Scholar
  13. A. González-Sarrías, J. Tomé-Carneiro, A. Bellesia, F. A. Tomás-Barberán, and J. C. Espín, “The ellagic acid-derived gut microbiota metabolite, urolithin A, potentiates the anticancer effects of 5-fluorouracil chemotherapy on human colon cancer cells,” Food & Function, vol. 6, no. 5, pp. 1460–1469, 2015. View at Publisher · View at Google Scholar · View at Scopus
  14. A. Aguilar-Galvez, G. Noratto, F. Chambi, F. Debaste, and D. Campos, “Potential of tara (Caesalpinia spinosa) gallotannins and hydrolysates as natural antibacterial compounds,” Food Chemistry, vol. 156, pp. 301–304, 2014. View at Publisher · View at Google Scholar · View at Scopus
  15. H. F. Ji, H. Y. Zhang, and L. Shen, “Proton dissociation is important to understanding structure-activity relationships of gallic acid antioxidants,” Bioorganic & Medicinal Chemistry Letters, vol. 16, no. 15, pp. 4095–4098, 2006. View at Google Scholar
  16. C.-H. Yoon, S.-J. Chung, S.-W. Lee, Y.-B. Park, S.-K. Lee, and M.-C. Park, “Gallic acid, a natural polyphenolic acid, induces apoptosis and inhibits proinflammatory gene expressions in rheumatoid arthritis fibroblast-like synoviocytes,” Joint Bone Spine, vol. 80, no. 3, pp. 274–279, 2013. View at Publisher · View at Google Scholar · View at Scopus
  17. J. Sun, Y.-Z. Li, Y.-H. Ding et al., “Neuroprotective effects of gallic acid against hypoxia/reoxygenation-induced mitochondrial dysfunctions in vitro and cerebral ischemia/reperfusion injury in vivo,” Brain Research, vol. 1589, pp. 126–139, 2014. View at Publisher · View at Google Scholar · View at Scopus